David Lebwohl
CIK 1810882 · EVP, Chief Medical Officer · last filed 2026-03-03
David Lebwohl is an EVP, Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for NTLA, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
1
21
-$2.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTLA | EVP, Chief Medical Officer | 131,192 | $12.11 | $1.59M | -$2.37M | 21 | 2026-03-03 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | NTLA | Grant (A) | +9,943 | $0 | EDGAR |
| 2026-01-07 | NTLA | Sell (S) | −11,903 | -$109.6K | EDGAR |
| 2025-03-04 | NTLA | Grant (A) | +43,200 | $0 | EDGAR |
| 2025-01-07 | NTLA | Sell (S) | −9,557 | -$116.4K | EDGAR |
| 2025-01-03 | NTLA | Exer (M) | +3,189 | $0 | EDGAR |
| 2024-03-05 | NTLA | Grant (A) | +38,701 | $0 | EDGAR |
| 2024-01-05 | NTLA | Sell (S) | −5,843 | -$172.1K | EDGAR |
| 2024-01-03 | NTLA | Exer (M) | +3,187 | $0 | EDGAR |
| 2023-03-03 | NTLA | Grant (A) | +30,674 | $0 | EDGAR |
| 2023-01-06 | NTLA | Sell (S) | −2,574 | -$95.8K | EDGAR |